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Introduction
Reactive (AA) amyloidosis may complicate Familial Medi-
terranean fever (FMF), the prototype of autoinflammatory
diseases. Thus, proteinuria in FMF is commonly viewed as
resulting from amyloidosis and kidney biopsy is deemed
superfluous. However, nephropathy other than amyloido-
sis has been described in FMF, but its rate and distinctive
characteristics are unknown.
Objectives
To determine the rate and underlying pathology of FMF
related non-amyloidotic proteinuria and compare its
clinical course, demographic and genetic features to
those of FMF-amyloid nephropathy.
Methods
This study is a retrospective analysis of data from all
FMF patients, undergoing kidney biopsy for proteinuria
above 0.5 gram/24 hrs, during 10 years (2001- 2011).
Clinical, laboratory, genetic and pathology data were
abstracted from patient files. Biopsies were viewed by an
experienced pathologist, as necessary.
Results
From 27 patients referred to kidney biopsy, only 16
(59.3%) were diagnosed with amyloid kidney disease
(AKD), 11 were diagnosed with another nephropathy. The
AKD and non amyloid kidney disease (NAKD) groups
were comparable on most variables, but showed distinct
characteristics with regard to the range of proteinuria
(6.46 ±4.3 g vs. 2.4±1.7 g, p= 0.0136), rate of severe FMF
(14 vs. 5 patients, p= 0.03) and rate of development of end
stage renal disease (75% vs. 27.2%, p=0.02) respectively.
Conclusion
NAKD is common in FMF and is featured with milder
course and better prognosis. Contrary to common
practice, it is highly suggested to obtain kidney biopsy
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